Pre-existing tumor host immunity characterization in resected non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)（2023）

引用 0|浏览11

暂无评分

摘要

TIME analysis in resected NSCLC highlighted differences by histology, PD-L1 expression and molecular subgroups. Biomarker studies using IHC might aid to individually tailor adjuvant treatment in early-stage NSCLC.

查看译文

关键词

Histology,PD-L1,Resected NSCLC,Tumor associated immune cells

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要